Temat: "BIOMARKERS" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review.
Autorzy:: Al-Tashi Q; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Saad MB; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Muneer A; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Qureshi R; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Mirjalili S; Centre for Artificial Intelligence Research and Optimization, Torrens University Australia, Fortitude Valley, Brisbane, QLD 4006, Australia.; Yonsei Frontier Lab, Yonsei University, Seoul 03722, Republic of Korea.; University Research and Innovation Center, Obuda University, 1034 Budapest, Hungary.
Sheshadri A; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Le X; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Vokes NI; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Zhang J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Wu J; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Apr 24; Vol. 24 (9). Date of Electronic Publication: 2023 Apr 24.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Biomarkers, Tumor*
Neoplasms*/diagnosis
Humans ; Prognosis ; Prospective Studies ; Biomarkers/analysis ; Precision Medicine ; Machine Learning

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: The issues and challenges with cancer biomarkers.
Autorzy:: Purkayastha K; Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Dhar R; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Pethusamy K; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Srivastava T; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Shankar A; Department of Radiotherapy, All India Institute of Medical Sciences, New Delhi, India.
Rath GK; Formerly Chief, IRCH, All India Institute of Medical Sciences, New Delhi; Ex-Director, NCI, Jhajjar, Haryana, India.
Karmakar S; Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.; Pokaż więcej
Źródło:: Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Apr; Vol. 19 (Supplement), pp. S20-S35.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Biomarkers, Tumor*/metabolism
Neoplasms*/diagnosis
Child ; Humans ; Biomarkers/metabolism ; Cost-Effectiveness Analysis

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: How Biomarkers of Response to Chemotherapy Might Change Patient Management.
Autorzy:: Hawkins WG; Department of Surgery, Washington University in St. Louis, St. Louis, MO, USA. .
Hammill CW; Department of Surgery, Washington University in St. Louis, St. Louis, MO, USA.
Ballentine SJ; Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO, USA.; Pokaż więcej
Źródło:: Annals of surgical oncology [Ann Surg Oncol] 2023 Feb; Vol. 30 (2), pp. 658-659. Date of Electronic Publication: 2022 Nov 23.
Typ publikacji:: Editorial
MeSH Terms:: Biomarkers, Tumor*
Humans ; Biomarkers

Opinia redakcyjna

na półce

Szczegóły

Skocz do pozycji: 4.

Tytuł:: Identification of prognostic and predictive biomarkers in high-dimensional data with PPLasso.
Autorzy:: Zhu W; Université Paris-Saclay, AgroParisTech, INRAE, UMR MIA Paris-Saclay, 91120, Palaiseau, France. .; Biostatistics and Programming Department, Sanofi R&D, 91380, Chilly Mazarin, France. .
Lévy-Leduc C; Université Paris-Saclay, AgroParisTech, INRAE, UMR MIA Paris-Saclay, 91120, Palaiseau, France.
Ternès N; Biostatistics and Programming Department, Sanofi R&D, 91380, Chilly Mazarin, France.; Pokaż więcej
Źródło:: BMC bioinformatics [BMC Bioinformatics] 2023 Jan 23; Vol. 24 (1), pp. 25. Date of Electronic Publication: 2023 Jan 23.
Typ publikacji:: Journal Article
MeSH Terms:: Proteomics*
Biomarkers, Tumor*
Humans ; Prognosis ; Biomarkers ; Models, Statistical ; Genomics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Self-Referenced Synthetic Urinary Biomarker for Quantitative Monitoring of Cancer Development.
Autorzy:: Wang F; State Key Laboratory of Medicinal Chemical Biology, Research Center for Analytical Sciences, and Tianjin Key Laboratory of Molecular Recognition and Biosensing, College of Chemistry, Nankai University, Tianjin 300071, China.
Sun N; State Key Laboratory of Medicinal Chemical Biology, Research Center for Analytical Sciences, and Tianjin Key Laboratory of Molecular Recognition and Biosensing, College of Chemistry, Nankai University, Tianjin 300071, China.
Li Q; State Key Laboratory of Medicinal Chemical Biology, Research Center for Analytical Sciences, and Tianjin Key Laboratory of Molecular Recognition and Biosensing, College of Chemistry, Nankai University, Tianjin 300071, China.
Yang J; State Key Laboratory of Medicinal Chemical Biology, Research Center for Analytical Sciences, and Tianjin Key Laboratory of Molecular Recognition and Biosensing, College of Chemistry, Nankai University, Tianjin 300071, China.
Yang X; Tianjin Institute of Urology, the 2nd Hospital of Tianjin Medical University, Tianjin 300211, China.
Liu D; State Key Laboratory of Medicinal Chemical Biology, Research Center for Analytical Sciences, and Tianjin Key Laboratory of Molecular Recognition and Biosensing, College of Chemistry, Nankai University, Tianjin 300071, China.; Pokaż więcej
Źródło:: Journal of the American Chemical Society [J Am Chem Soc] 2023 Jan 18; Vol. 145 (2), pp. 919-928. Date of Electronic Publication: 2022 Dec 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Neoplasms*/diagnosis
Biomarkers, Tumor*/urine
Humans ; Biomarkers/urine ; Gold/chemistry ; Kidney ; Metal Nanoparticles/chemistry ; Spectrum Analysis, Raman/methods ; Tumor Microenvironment

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 6.

Tytuł:: CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma.
Autorzy:: Su Q; Department of Hepatopancreatobiliary Surgery, The Affiliated Calmette Hospital of Kunming Medical University, 1228 Beijing Road, Panlong District, Kunming City, 650224, Yunnan Province, China.
Li L; Department of Hepatopancreatobiliary Surgery, The Affiliated Calmette Hospital of Kunming Medical University, 1228 Beijing Road, Panlong District, Kunming City, 650224, Yunnan Province, China.
Li X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming City, Yunnan Province, China.
Li W; Department of Hepatopancreatobiliary Surgery, The Affiliated Calmette Hospital of Kunming Medical University, 1228 Beijing Road, Panlong District, Kunming City, 650224, Yunnan Province, China.
Zhang X; Department of Hepatopancreatobiliary Surgery, The Affiliated Calmette Hospital of Kunming Medical University, 1228 Beijing Road, Panlong District, Kunming City, 650224, Yunnan Province, China.
Dong Y; Department of Hepatopancreatobiliary Surgery, The Affiliated Calmette Hospital of Kunming Medical University, 1228 Beijing Road, Panlong District, Kunming City, 650224, Yunnan Province, China.
Han L; Department of Hepatopancreatobiliary Surgery, The Affiliated Calmette Hospital of Kunming Medical University, 1228 Beijing Road, Panlong District, Kunming City, 650224, Yunnan Province, China.
Wang D; Department of Hepatopancreatobiliary Surgery, The Affiliated Calmette Hospital of Kunming Medical University, 1228 Beijing Road, Panlong District, Kunming City, 650224, Yunnan Province, China.
Ran J; Department of Hepatopancreatobiliary Surgery, The Affiliated Calmette Hospital of Kunming Medical University, 1228 Beijing Road, Panlong District, Kunming City, 650224, Yunnan Province, China. .; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2022 Dec 04; Vol. 20 (1), pp. 382. Date of Electronic Publication: 2022 Dec 04.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/immunology
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/immunology
Liver Neoplasms*/pathology
Receptors, G-Protein-Coupled*/genetics
Receptors, G-Protein-Coupled*/immunology
Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/immunology
Humans ; Biomarkers ; RNA, Messenger/genetics ; RNA, Messenger/immunology ; Tumor-Associated Macrophages/immunology ; Databases, Factual

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Advances in the DNA Nanotechnology for the Cancer Biomarkers Analysis: Attributes and Applications.
Autorzy:: Xia LY; Biliary Surgical Department of West China Hospital, Sichuan University, Chengdu, Sichuan 610064, PR China; Analytical & Testing Center, Sichuan University, Chengdu, Sichuan 610064, PR China.
Tang YN; Analytical & Testing Center, Sichuan University, Chengdu, Sichuan 610064, PR China.
Zhang J; Biliary Surgical Department of West China Hospital, Sichuan University, Chengdu, Sichuan 610064, PR China.
Dong TY; College of Chemistry, Sichuan University Chengdu, Sichuan 610064, PR China.
Zhou RX; Biliary Surgical Department of West China Hospital, Sichuan University, Chengdu, Sichuan 610064, PR China. Electronic address: .; Pokaż więcej
Źródło:: Seminars in cancer biology [Semin Cancer Biol] 2022 Nov; Vol. 86 (Pt 2), pp. 1105-1119. Date of Electronic Publication: 2022 Jan 01.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Biomarkers, Tumor*/analysis
Neoplasms*/diagnosis
Neoplasms*/genetics
Neoplasms*/metabolism
Humans ; Nanotechnology/methods ; DNA ; Enzyme-Linked Immunosorbent Assay/methods ; Biomarkers

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 8.

Tytuł:: Leukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma.
Autorzy:: Cardoso-Vigueros C; Department of Allergy, University Hospital of Zurich, Zurich, Switzerland.
von Blumenthal T; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Rückert B; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Rinaldi AO; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Tan G; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Dreher A; Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Radzikowska U; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.; Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Menz G; Hochgebirgsklinik Davos (HGK), Davos, Switzerland.
Schmid-Grendelmeier P; Department of Allergy, University Hospital of Zurich, Zurich, Switzerland.; Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Akdis CA; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.; Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Sokolowska M; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.; Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.; Pokaż więcej
Źródło:: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2022 Oct; Vol. 52 (10), pp. 1183-1194. Date of Electronic Publication: 2022 Apr 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Asthma*/diagnosis
Asthma*/drug therapy
Asthma*/genetics
Environmental Biomarkers*
Adrenal Cortex Hormones/therapeutic use ; Allergens ; Biomarkers ; Eosinophils ; Humans ; Immunoglobulin E ; Leukocyte Count ; Leukocytes

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 9.

Tytuł:: Hemolymph Glycemia as an Environmental Stress Biomarker in the Invasive Red Swamp Crayfish ( Procambarus clarkii ).
Autorzy:: Soares MC
Banha F
Cardoso SC
Gama M
Xavier R
Ribeiro L
Anastácio P; Pokaż więcej
Źródło:: Physiological and biochemical zoology : PBZ [Physiol Biochem Zool] 2022 May-Jun; Vol. 95 (3), pp. 265-277.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Astacoidea*/physiology
Environmental Biomarkers*
Animals ; Biomarkers ; Blood Glucose ; Glucose ; Hemolymph

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 10.

Tytuł:: Non-Invasive, Topical Sampling of Potential, Low-Molecular Weight, Skin Cancer Biomarkers: A Study on Healthy Volunteers.
Autorzy:: Jankovskaja S; Department of Biomedical Science, Malmö University, Malmö 214 28, Sweden.; Biofilms─Research Center for Biointerfaces, Malmö University, Malmö 214 28, Sweden.
Morin M; Department of Biomedical Science, Malmö University, Malmö 214 28, Sweden.; Biofilms─Research Center for Biointerfaces, Malmö University, Malmö 214 28, Sweden.
Gustafsson A; Department of Biomedical Science, Malmö University, Malmö 214 28, Sweden.; Biofilms─Research Center for Biointerfaces, Malmö University, Malmö 214 28, Sweden.
Anderson CD; Department of Biomedical and Clinical Sciences, Linköping University, Linköping 581 83, Sweden.; Department of Dermatology and Venereology, Linköping 581 83, Sweden.
Lehoczki B; Department of Biomedical Science, Malmö University, Malmö 214 28, Sweden.; Biofilms─Research Center for Biointerfaces, Malmö University, Malmö 214 28, Sweden.
Engblom J; Department of Biomedical Science, Malmö University, Malmö 214 28, Sweden.; Biofilms─Research Center for Biointerfaces, Malmö University, Malmö 214 28, Sweden.
Björklund S; Department of Biomedical Science, Malmö University, Malmö 214 28, Sweden.; Biofilms─Research Center for Biointerfaces, Malmö University, Malmö 214 28, Sweden.
Rezeli M; Clinical Protein Science and Imaging, Department of Biomedical Engineering, Lund University, Lund 221 00, Sweden.
Marko-Varga G; Clinical Protein Science and Imaging, Department of Biomedical Engineering, Lund University, Lund 221 00, Sweden.
Ruzgas T; Department of Biomedical Science, Malmö University, Malmö 214 28, Sweden.; Biofilms─Research Center for Biointerfaces, Malmö University, Malmö 214 28, Sweden.; Pokaż więcej
Źródło:: Analytical chemistry [Anal Chem] 2022 Apr 19; Vol. 94 (15), pp. 5856-5865. Date of Electronic Publication: 2022 Apr 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Biomarkers, Tumor*
Skin Neoplasms*/diagnosis
Biomarkers ; Healthy Volunteers ; Humans ; Kynurenine/metabolism ; Molecular Weight ; Phenylalanine ; Tryptophan/metabolism ; Tyrosine

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 11.

Tytuł:: Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR study.
Autorzy:: Hernández C; Diabetes and Metabolism Research Unit and CIBERDEM, Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, Passeig de La Vall d'Hebron, 119-129, 08035, Barcelona, Spain. .
Simó-Servat O; Diabetes and Metabolism Research Unit and CIBERDEM, Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, Passeig de La Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
Porta M; Department of Medical Sciences, University of Turin, Turin, Italy.
Grauslund J; Research Unit of Ophthalmology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Harding SP; Department of Eye and Vision Science, Institute of Life Course and Medical Sciences, University of Liverpool, and St. Paul's Eye Unit. Liverpool University Hospitals, Liverpool, UK.
Frydkjaer-Olsen U; Research Unit of Ophthalmology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
García-Arumí J; Department of Ophthalmology, Vall d'Hebron University Hospital, Barcelona, Spain.
Ribeiro L; Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal.
Scanlon P; Gloucestershire Hospitals National Health Service Foundation Trust, Cheltenham, UK.
Cunha-Vaz J; Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal.
Simó R; Diabetes and Metabolism Research Unit and CIBERDEM, Vall d'Hebron Research Institute, Vall d'Hebron Barcelona Hospital Campus, Passeig de La Vall d'Hebron, 119-129, 08035, Barcelona, Spain.; Pokaż więcej
Corporate Authors:: European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)
Źródło:: Acta diabetologica [Acta Diabetol] 2023 Jun; Vol. 60 (6), pp. 837-844. Date of Electronic Publication: 2023 Mar 23.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers*
Diabetes Mellitus, Type 2*/complications
Diabetic Retinopathy*/diagnosis
Diabetic Retinopathy*/etiology
Glial Fibrillary Acidic Protein*
Humans ; Case-Control Studies ; Intermediate Filaments ; Neurodegenerative Diseases

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 12.

Tytuł:: Identify Potential Urine Biomarkers for Bladder Cancer Prognosis Using NGS Data Analysis and Experimental Validation.
Autorzy:: Ren R; Department of Urology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Wang H; Department of Urology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Xie L; Department of Urology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Muthupandian S; AMR and Nanomedicine Lab, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, 600077, India.
Yang X; Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, 030000, China. .; Pokaż więcej
Źródło:: Applied biochemistry and biotechnology [Appl Biochem Biotechnol] 2023 May; Vol. 195 (5), pp. 2947-2964. Date of Electronic Publication: 2022 Nov 30.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor*/genetics
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/metabolism
Humans ; Aquaporin 2 ; Prognosis ; RNA, Messenger/genetics ; Extracellular Matrix Proteins/metabolism ; Membrane Proteins/metabolism

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 13.

Tytuł:: Increased Kremen2 predicts worse prognosis in colon cancer.
Autorzy:: Long J; Division of Colorectal and Anal Surgery, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Department of Breast and Thyroid Surgery, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Cong F; Division of Colorectal and Anal Surgery, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Department of Gastroenteroanal Surgery, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Wei Y; Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Liu J; Division of Colorectal and Anal Surgery, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Guangxi Clinical Research Center for Colorectal Cancer, Nanning, Guangxi, China.
Tang W; Division of Colorectal and Anal Surgery, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Guangxi Clinical Research Center for Colorectal Cancer, Nanning, Guangxi, China.; Pokaż więcej
Źródło:: Pathology oncology research : POR [Pathol Oncol Res] 2023 Apr 12; Vol. 29, pp. 1611082. Date of Electronic Publication: 2023 Apr 12 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Colonic Neoplasms*/pathology
Humans ; Prognosis ; Lymphatic Metastasis ; RNA, Messenger

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 14.

Tytuł:: Toward Personalized Nanomedicine: The Critical Evaluation of Micro and Nanodevices for Cancer Biomarker Analysis in Liquid Biopsy.
Autorzy:: Clack K; School of Environment and Science (ESC), Griffith University, Nathan Campus, Nathan, QLD, 4111, Australia.; Queensland Micro and Nanotechnology Centre (QMNC), Griffith University, Nathan Campus, Nathan, QLD, 4111, Australia.
Soda N; Queensland Micro and Nanotechnology Centre (QMNC), Griffith University, Nathan Campus, Nathan, QLD, 4111, Australia.
Kasetsirikul S; Queensland Micro and Nanotechnology Centre (QMNC), Griffith University, Nathan Campus, Nathan, QLD, 4111, Australia.
Mahmudunnabi RG; School of Environment and Science (ESC), Griffith University, Nathan Campus, Nathan, QLD, 4111, Australia.; Queensland Micro and Nanotechnology Centre (QMNC), Griffith University, Nathan Campus, Nathan, QLD, 4111, Australia.
Nguyen NT; Queensland Micro and Nanotechnology Centre (QMNC), Griffith University, Nathan Campus, Nathan, QLD, 4111, Australia.
Shiddiky MJA; School of Environment and Science (ESC), Griffith University, Nathan Campus, Nathan, QLD, 4111, Australia.; Queensland Micro and Nanotechnology Centre (QMNC), Griffith University, Nathan Campus, Nathan, QLD, 4111, Australia.; Pokaż więcej
Źródło:: Small (Weinheim an der Bergstrasse, Germany) [Small] 2023 Apr; Vol. 19 (15), pp. e2205856. Date of Electronic Publication: 2023 Jan 11.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Biomarkers, Tumor*
Neoplasms*/diagnosis
Humans ; Nanomedicine ; Liquid Biopsy/methods ; Nanotechnology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 15.

Tytuł:: Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis.
Autorzy:: Ding H; Department of Rheumatology, Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University School of Medicine, 145 Shandong (M) Rd, Shanghai, 200001, China.; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Shen Y; Department of Rheumatology, Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University School of Medicine, 145 Shandong (M) Rd, Shanghai, 200001, China.
Lin C; Department of Rheumatology, Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University School of Medicine, 145 Shandong (M) Rd, Shanghai, 200001, China.
Qin L; Department of Nephrology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
He S; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Dai M; Department of Rheumatology, Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University School of Medicine, 145 Shandong (M) Rd, Shanghai, 200001, China.
Okitsu SL; EMD Serono (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, USA.
DeMartino JA; EMD Serono (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, USA.
Guo Q; Department of Rheumatology, Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University School of Medicine, 145 Shandong (M) Rd, Shanghai, 200001, China. .
Shen N; Department of Rheumatology, Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University School of Medicine, 145 Shandong (M) Rd, Shanghai, 200001, China.; China-Australia Centre for Personalized Immunology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Pokaż więcej
Źródło:: Arthritis research & therapy [Arthritis Res Ther] 2022 Mar 28; Vol. 24 (1), pp. 77. Date of Electronic Publication: 2022 Mar 28.
Typ publikacji:: Journal Article
MeSH Terms:: Antigens, Neoplasm*/urine
Biomarkers, Tumor*/urine
Kidney*/pathology
Lupus Nephritis*/pathology
Biomarkers/metabolism ; Cross-Sectional Studies ; Galectin 3 ; Humans

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 16.

Tytuł:: The role of cystatin C in multiple myeloma.
Autorzy:: Zhang J; Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Jiang Y; Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Guo D; Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Liu HY; Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Hong L; Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Qi J; Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Huang H; Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.; Pokaż więcej
Źródło:: International journal of laboratory hematology [Int J Lab Hematol] 2022 Feb; Vol. 44 (1), pp. 135-141. Date of Electronic Publication: 2021 Sep 22.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers*
Cystatin C/*blood
Multiple Myeloma/*blood
Multiple Myeloma/*mortality
Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor ; Disease Management ; Disease Progression ; Disease Susceptibility ; Female ; Humans ; Male ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/etiology ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: The Prognostic Effect of HER2 Gene Amplification in High-Grade Endometrial Carcinomas and its Correlation with Protein Overexpression.
Autorzy:: Bozkurt KK; Department of Pathology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
Çiriş İM; Department of Pathology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
Başpınar Ş; Department of Pathology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
Çetin B; Department of Medical Oncology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
Erdemoğlu E; Department of Gynecologic Oncology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
Bircan S; Department of Pathology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
Ertunç O; Department of Pathology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.; Pokaż więcej
Źródło:: International journal of surgical pathology [Int J Surg Pathol] 2023 Jun; Vol. 31 (4), pp. 365-374. Date of Electronic Publication: 2022 May 25.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor*/genetics
Endometrial Neoplasms*/diagnosis
Endometrial Neoplasms*/genetics
Endometrial Neoplasms*/metabolism
Receptor, ErbB-2*/metabolism
Female ; Humans ; Gene Amplification ; In Situ Hybridization, Fluorescence ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.
Autorzy:: Tundidor I; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.
Seijo-Vila M; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.
Blasco-Benito S; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.
Rubert-Hernández M; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.
Adámez S; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.
Andradas C; Brain Tumor Research Program, Telethon Kids Institute, Nedlands, WA, Australia.; Centre for Child Health Research, University of Western Australia, Nedlands, WA, Australia.
Manzano S; Breast Cancer Group, Oncology Area, Biodonostia Health Research Institute, San Sebastián, Spain.
Álvarez-López I; Breast Cancer Group, Oncology Area, Biodonostia Health Research Institute, San Sebastián, Spain.; Gipuzkoa Cancer Unit, OSI Donostialdea-Onkologikoa Foundation, San Sebastián, Spain.
Sarasqueta C; Unit of Information and Healthcare Results, OSI Donostialdea, Biodonostia Health Research Institute, San Sebastián, Spain.; Methodological Support Unit, Biodonostia Health Research Institute, San Sebastián, Spain.
Villa-Morales M; Centro de Biología Molecular Severo Ochoa (CBMSO) (CSIC-UAM), Madrid, Spain.; Department of Biology, Autonomous University of Madrid, Madrid, Spain.
González-Lois C; Department of Pathology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Ramírez-Medina E; Department of Obstetrics & Gynecology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Almoguera B; Department of Obstetrics & Gynecology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Sánchez-López AJ; Biobank Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.; Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA), Madrid, Spain.
Bindila L; Clinical Lipidomics Unit, Institute of Physiological Chemistry, University Medical Center, Mainz, Germany.
Hamann S; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Kiel, Germany.
Arnold N; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Kiel, Germany.
Röcken C; Institute of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany.
Heras-Murillo I; Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Sancho D; Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Moreno-Bueno G; MD Anderson International Foundation; Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM); Department of Biochemistry, Autonomous University of Madrid; Instituto de Investigación Hospital Universitario La Paz (IdiPaz); Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Caffarel MM; Breast Cancer Group, Oncology Area, Biodonostia Health Research Institute, San Sebastián, Spain.; Ikerbasque-Basque Foundation for Science, Bilbao, Spain.
Guzmán M; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain.; Instituto Ramón y Cajal de Investigación Sanitaria y Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Sánchez C; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain. .; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain. .
Pérez-Gómez E; Department of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain. .; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain. .; Pokaż więcej
Źródło:: Nature communications [Nat Commun] 2023 May 30; Vol. 14 (1), pp. 3130. Date of Electronic Publication: 2023 May 30.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor*
Lung Neoplasms*/pathology
Mice ; Animals ; Neoplasm Recurrence, Local/pathology ; Amidohydrolases/genetics

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 19.

Tytuł:: [Approach to the Patients with Elevated CA 19-9].
Autorzy:: Choe JW; Division of Gastroenterology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.; Pokaż więcej
Źródło:: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi [Korean J Gastroenterol] 2023 May 25; Vol. 81 (5), pp. 185-188.
Typ publikacji:: English Abstract; Journal Article; Review
MeSH Terms:: Anxiety*
Biomarkers, Tumor*
Humans ; CA-19-9 Antigen ; Emotions ; Gastrointestinal Tract

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 20.

Tytuł:: Novel characteristics for immunophenotype, FISH pattern and molecular cytogenetics in synovial sarcoma.
Autorzy:: Zhong LL; Department of Pathology, The 924th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Guangxi Key Laboratory of Metabolic Diseases Research, Guilin, 541002, Guangxi, China.; Guangxi Key Laboratory of Glucose and Lipid Metabolic Diseases, The Second Affiliated Hospital of Guilin Medical University, Guilin, 541199, Guangxi, China.
Huang GX; Department of Pathology, The 924th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Guangxi Key Laboratory of Metabolic Diseases Research, Guilin, 541002, Guangxi, China.
Xian LY; Department of Pathology and Laboratory Medicine, Dongguan Affiliated Hospital of Southern Medical University, Dongguan, 523059, Guangdong, China.
Wei ZC; Department of Pathology, The 924th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Guangxi Key Laboratory of Metabolic Diseases Research, Guilin, 541002, Guangxi, China.
Tang ZP; Department of Pathology, The 924th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Guangxi Key Laboratory of Metabolic Diseases Research, Guilin, 541002, Guangxi, China.
Chen QY; Department of Pathology, The 924th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Guangxi Key Laboratory of Metabolic Diseases Research, Guilin, 541002, Guangxi, China.
Chen H; Department of Pathology, The 924th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Guangxi Key Laboratory of Metabolic Diseases Research, Guilin, 541002, Guangxi, China.
Tang F; Department of Pathology, The 924th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Guangxi Key Laboratory of Metabolic Diseases Research, Guilin, 541002, Guangxi, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 May 16; Vol. 13 (1), pp. 7954. Date of Electronic Publication: 2023 May 16.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor*/genetics
Sarcoma, Synovial*/pathology
Humans ; Retrospective Studies ; Oncogene Proteins, Fusion/genetics ; Translocation, Genetic ; Cytogenetic Analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""BIOMARKERS"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język